Erik Nelson is a trained endocrinologist with specific expertise in nuclear receptor pharmacology. He has made significant contributions to the fields of reproductive physiology, pharmacology, bone biology and cancer biology. Breast cancer remains the most commonly...
John Katzenellenbogen directs a research program that intersects chemistry, biology, and medical applications with a particular focus on the action of estrogens in breast cancer and androgens in prostate cancer. His interests are in addressing key problems in...
Benita Katzenellenbogen’s research in cancer, endocrinology, and women’s health has been focused on nuclear receptors, especially estrogen receptors, and their mechanistic, physiological, and integrative actions, with the goal to improve the effectiveness of...
Stephen Sligar has spent his professional career focused on the discovery, development, and use of chemical and biophysical tools to understand fundamental problems in biochemistry. Sligar’s lab developed the Nanodisc platform, which allows for the generation of a...
David Shapiro’s lab has spent over a decade studying estrogens, acting via estrogen receptor a (ERa), which plays a key role in most breast cancers. The Shapiro laboratory has leveraged its expertise in ERa action in cancer to identify new pathways of hormone action...
Jodi Flaws and her lab are interested in chemicals, such as pesticides and plasticizers, that affect female reproductive development and function, as well as chemical exposures associated with adverse female menopausal outcomes. She has many years of experience...
